Compare
5 stocks, side by sideRelative performance · rebased to 100
NAMSCRNXTLXRCUSRLAY
| NAMSNewAmsterdam Pharma Company N.V. | CRNXCrinetics Pharmaceuticals, Inc. | TLXTelix Pharmaceuticals Limited | RCUSArcus Biosciences, Inc. | RLAYRelay Therapeutics, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 3/10 | 9/10 | - | 6/10 | 7/10 |
| Price | $25.66 | $84.96 | $12.00 | $29.02 | $19.09 |
| 1 month | -7.1% | +1.3% | +13% | +2.2% | -3.1% |
| 1 year | +1.0% | +210% | +0.84% | +177% | +450% |
| 5 year | +165% | +384% | - | +5.8% | -42% |
| P/E (TTM) | -14.4 | -16.5 | - | -9.2 | -12.2 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $3.7B | $3.7B | $3.7B | $3.8B | $3.9B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.